Characterization of T cell epitopes of the receptor for hyaluronic acid mediated motility (RHAMM/CD168) in acute myeloid leukemia.

被引：0
|
作者：
Schmitt, M
Li, L
Ringhoffer, M
Barth, T
Wiesneth, M
Dohner, H
Greiner, J
机构：
[1] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany
[2] Univ Ulm, Inst Pathol, D-7900 Ulm, Germany
[3] German Red Cross, Inst Immunogenet & Clin Transfus Med, Ulm, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2540
引用
收藏
页码：696A / 696A
页数：1
相关论文
共 50 条
  • [11] Mice With Targeted Deletion of Receptor for Hyaluronan-Mediated Motility (RHAMM, CD168) Are Protected From Bleomycin-Induced Lung Injury
    Savani, Rashmin C.
    Cheong, Naeun
    Mitchell, Jason
    Al-Saadi, Rajiha
    Liao, Jie
    FASEB JOURNAL, 2010, 24
  • [12] Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia
    Grenier, J
    Ringhoffer, M
    Taniguchi, M
    Schmitt, A
    Kirchner, D
    Krähn, G
    Heilmann, V
    Gschwend, J
    Bergmann, L
    Döhner, H
    Schmitt, M
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (09) : 1029 - 1035
  • [13] The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury
    Cui, Zheng
    Liao, Jie
    Cheong, Naeun
    Longoria, Christopher
    Cao, Gaoyuan
    DeLisser, Horace M.
    Savani, Rashmin C.
    MATRIX BIOLOGY, 2019, 78-79 : 255 - 271
  • [14] Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM)
    Ziebell, MR
    Prestwich, GD
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2004, 18 (10) : 597 - 614
  • [15] Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM)
    Michael R. Ziebell
    Glenn D. Prestwich
    Journal of Computer-Aided Molecular Design, 2004, 18 : 597 - 614
  • [16] The receptor for hyaluronan acid mediator motility (RHAMM, CD168) expression in EMT-like cancer cells is a predictor of tumor progression in colorectal cancer
    Mele, Valentina
    Koelzer, Viktor H.
    Huber, Bettina
    Muraro, Manuele G.
    Pfaff, Dennis
    Iezzi, Giandomenica
    Terracciano, Luigi M.
    Karamitopoulou, Eva
    Zlobec, Inti
    Lugli, Alessandro
    CANCER RESEARCH, 2014, 74 (19)
  • [17] The receptor for hyaluronic acid mediated motility (RHAMM): Characterization as an immunotherapeutical target in chronic lymphocytic leukemia (CLL) and first results of RHAMM-derived peptide vaccination trial
    Giannopoulos, Krzysztof
    Buhler, Andreas
    Chen, Jinfei
    Krober, Alexander
    Kowal, Malgorzata
    Dmoszynska, Anna
    Rolinski, Jacek
    Greiner, Jochen
    Dohner, Hartmut
    Stilgenbauer, Stephan
    Schmitt, Michael
    BLOOD, 2007, 110 (11) : 611A - 611A
  • [18] RHAMM/CD168 might represent potential target for immunotherapy of patients with B-cell chronic lymphocytic leukemia
    Giannopoulos, K.
    Hus, I.
    Li, L.
    Bojarska-Junak, A.
    Greiner, J.
    Rolinski, J.
    Dmoszynska, A.
    Doehner, H.
    Schmitt, M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (03) : 417 - 417
  • [19] Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors
    Yang, Chenchen
    Li, Cheng
    Zhang, Peng
    Wu, Wei
    Jiang, Xiqun
    THERANOSTICS, 2017, 7 (06): : 1719 - 1734
  • [20] Stretch injury in the rat bladder activates the matrix receptor RHAMM (receptor for hyaluronic acid mediated motility)
    Bägli, DJ
    Joyner, BD
    Mahoney, SR
    JOURNAL OF UROLOGY, 1998, 159 (05): : 77 - 77
12345